1. Home
  2. KPTI vs ISSC Comparison

KPTI vs ISSC Comparison

Compare KPTI & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KPTI
  • ISSC
  • Stock Information
  • Founded
  • KPTI 2008
  • ISSC 1988
  • Country
  • KPTI United States
  • ISSC United States
  • Employees
  • KPTI N/A
  • ISSC N/A
  • Industry
  • KPTI Biotechnology: Pharmaceutical Preparations
  • ISSC EDP Services
  • Sector
  • KPTI Health Care
  • ISSC Technology
  • Exchange
  • KPTI Nasdaq
  • ISSC Nasdaq
  • Market Cap
  • KPTI 103.5M
  • ISSC 135.8M
  • IPO Year
  • KPTI 2013
  • ISSC 2000
  • Fundamental
  • Price
  • KPTI $0.64
  • ISSC $8.15
  • Analyst Decision
  • KPTI Strong Buy
  • ISSC
  • Analyst Count
  • KPTI 4
  • ISSC 0
  • Target Price
  • KPTI $5.00
  • ISSC N/A
  • AVG Volume (30 Days)
  • KPTI 1.0M
  • ISSC 78.0K
  • Earning Date
  • KPTI 11-05-2024
  • ISSC 12-19-2024
  • Dividend Yield
  • KPTI N/A
  • ISSC N/A
  • EPS Growth
  • KPTI N/A
  • ISSC 15.54
  • EPS
  • KPTI N/A
  • ISSC 0.40
  • Revenue
  • KPTI $148,442,000.00
  • ISSC $47,198,020.00
  • Revenue This Year
  • KPTI $6.67
  • ISSC $44.00
  • Revenue Next Year
  • KPTI $8.58
  • ISSC $10.93
  • P/E Ratio
  • KPTI N/A
  • ISSC $20.38
  • Revenue Growth
  • KPTI 1.77
  • ISSC 35.59
  • 52 Week Low
  • KPTI $0.63
  • ISSC $4.91
  • 52 Week High
  • KPTI $1.95
  • ISSC $8.69
  • Technical
  • Relative Strength Index (RSI)
  • KPTI 25.28
  • ISSC 62.28
  • Support Level
  • KPTI $0.75
  • ISSC $7.36
  • Resistance Level
  • KPTI $0.83
  • ISSC $7.93
  • Average True Range (ATR)
  • KPTI 0.05
  • ISSC 0.25
  • MACD
  • KPTI -0.01
  • ISSC -0.01
  • Stochastic Oscillator
  • KPTI 4.21
  • ISSC 69.30

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Advanced Global Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

Share on Social Networks: